Is Tamoxifen Effective In Curing Breast Cancer?

Is Tamoxifen Effective In Curing Breast Cancer?
By Camry James

Tamoxifen, known in the trade as Nolvadex, is usually
prescribed by specialists in and is taken in pill
form. A patient will stay on the drug for about five years.

Often the woman's cancer will be tested to see if it is
sensitive to the amount of oestrogen in the system. If the
cancer is oestrogen sensitive, tamoxifen will be given.

Because tamoxifen is such a weak estrogen, its estrogen signals
don't stimulate very much cell growth. And because it has stolen
the place away from more powerful estrogen, it blocks
estrogen-stimulated cancer cell growth. In this way, tamoxifen
acts like an "anti-estrogen."

Tamoxifen may also take the place of natural estrogen in the
receptors of healthy breast cells. In that way it holds down
growth activity, and possibly stops abnormal growth and the
development of a totally new breast cancer. By blocking natural
estrogen from getting to the receptors, tamoxifen is helpful in
reducing the risk of in women at high risk who
have never had breast cancer. It also can help women who have
already had in one breast by lowering the risk of
a new forming in the other breast.

One study found that radiation plus tamoxifen was much better
than tamoxifen alone at reducing the risk of breast cancer
coming back after a lumpectomy in women with
hormone-receptor-positive breast cancer. This was true even for
women with very small cancers.

For pre-menopausal women,

Experiment seeks blood test for breast cancer (Reuters)
Reuters - An experimental approach that looks for the DNA leaking out from dead and dying cells may provide a route to a blood test for breast cancer, U.S. researchers reported on Tuesday.
Breast Cancer Patients Often Confused by Genomic Testing (HealthDay)
HealthDay - MONDAY, March 8 (HealthDay News) -- Doctors need to do a better job of explaining genomic test results to breast cancer patients, say U.S. researchers.
Certain Bone Drugs May Lower Breast Cancer Risk (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) -- Some types of bone-building drugs used to prevent and treat osteoporosis might reduce the risk of breast cancer, according to new research.
Freezing Technique May Stop Breast Cancer (HealthDay)
HealthDay - FRIDAY, March 5 (HealthDay News) -- Freezing breast tumors helped stop the spread of the cancer in mice, a new study has found.
Radiation Most Effective Soon After Breast Cancer Surgery (HealthDay)
HealthDay - THURSDAY, March 4 (HealthDay News) -- For women who have had breast cancer surgery, the question of whether or not to wait before receiving radiation therapy has been answered by new research that suggests that the longer women wait, the greater the chance of cancer recurrence.
Plant-focused diet may curb breast cancer risk (Reuters)
Reuters - Diets high in vegetables, fruits and soy might cut the risk of developing breast cancer by 30 percent, new research suggests.
Preventive Mastectomy in Opposite Breast Boosts Survival Only Slightly (HealthDay)
HealthDay - THURSDAY, Feb. 25 (HealthDay News) -- Women with breast cancer who choose to have a preventive mastectomy on their disease-free breast do reduce their risk of cancer in that breast, studies have shown.
Access to Mammograms Drops After Guidelines Change (HealthDay)
HealthDay - TUESDAY, Feb. 23 (HealthDay News) -- In some states, access to mammograms for women ages 40 to 49 has decreased since new breast cancer screening guidelines were released in November by the U.S. Preventive Services Task Force, according to a new survey.
Bitter Melon Extract May Slow, Stop Breast Cancer (HealthDay)
HealthDay - TUESDAY, Feb. 23 (HealthDay News) -- A popular nutritional supplement -- extract of bitter melon -- may help protect women from breast cancer, researchers say.
Mammogram Plus MRI Cost-Effective in High-Risk Women (HealthDay)
HealthDay - TUESDAY, Feb. 23 (HealthDay News) -- Annual screening with both mammography and MRI appears to be a cost-effective way to improve life expectancy in women at high risk for breast cancer, U.S. researchers say.

tamoxifen is the best hormonal
therapy. But tamoxifen is no longer the first choice for
post-menopausal women. If you've been on tamoxifen for two to
three years and now you're in menopause, your doctor may
recommend that you switch to an aromatase inhibitor to finish
your five years of hormonal therapy. However, you can still get
a lot of benefit if you take tamoxifen for up to five years and
then switch to an aromatase inhibitor.

Tamoxifen was first used to fight at the Christie
Hospital in Manchester, England, in 1969. It has since proved
its worth as means of stopping the spread or recurrence of the
disease in women who have already been treated for it.

But, it was noticed back in the early 1980s that some women who
were receiving the drug for cancer in one breast did not develop
any tumorous growth in the other. This prompted the suggestion
that Tamoxifen might have another preventative role for those
women who are at risk of getting but have yet to
develop any signs of the disease.

About the Author: Tamoxifen has been proven to be the cure to
Breast Cancer. We urge you to find out more about Tamoxifen at
http://Tamoxifen.eask.info

Source: http://www.isnare.com

Permanent Link:
http://www.isnare.com/?aid=67416&ca=Medicines+and+Remedies